Endoscopic v radiological techniques for rectal bleeding.

por Charnley, R M
Publicado 1989

Intraoperative abdominal ultrasound.

por Charnley, R M, Hardcastle, J D
Publicado 1990

Surgery for pancreatic cancer.

por Charnley, R. M., Spiller, R. C., Doran, J.
Publicado 1994

Evaluation of a Biopsy Gun for Guided Biopsy of Impalpable Liver Lesions Using Intraoperative Utrasound

por Charnley, R. M., Sheffield, J. P., Hardcastle, J. D.
Publicado 1990

Serum gastrin concentrations in colorectal cancer patients.

por Charnley, R. M., Thomas, W. M., Stanley, J., Morris, D. L.
Publicado 1992

Family History of Cancer and Tobacco Exposure in Index Cases of Pancreatic Ductal Adenocarcinoma

por Lochan, R., Daly, A. K., Reeves, H. L., Charnley, R. M.
Publicado 2011

The development and evolution of a tertiary pancreaticobiliary endoscopic ultrasound service: lessons learned

por Oppong, K W, Richardson, D L, Charnley, R M, Nayar, M K
Publicado en Frontline Gastroenterol (2011)

Radiofrequency Ablation Resulting in Left Lobe Hypertrophy and Improved Resectability

por Jones, R.T., French, J.J., Scott, J., Manas, D.M., Charnley, R.M.
Publicado 2011

A matrix metalloproteinase inhibitor to treat unresectable cholangiocarcinoma

por French, J. J, Midwinter, M. J., Bennett, M. K., Manas, D. M., Charnley, R. M.
Publicado 2005

Soluble E-Cadherin: An Early Marker of Severity in Acute Pancreatitis

por Sewpaul, A., French, J. J., Khoo, T. K., Kernohan, M., Kirby, J. A., Charnley, R. M.
Publicado 2009

T cell adhesion and cytolysis of pancreatic cancer cells: a role for E-cadherin in immunotherapy?

por French, J J, Cresswell, J, Wong, W K, Seymour, K, Charnley, R M, Kirby, J A
Publicado 2002

Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy – implications for timing of resectional surgery and use of biliary...

por Mansfield, S. D., Sen, G., Oppong, K., Jacques, B. C., O'Suilleabhain, C. B., Manas, D. M., Charnley, R. M.
Publicado 2006

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given...

por Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G., Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, A., Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W.
Publicado en Br J Cancer (2018)

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer

por Elander, N. O., Aughton, K., Ghaneh, P., Neoptolemos, J. P., Palmer, D. H., Cox, T. F., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G, Valle, J. W., McDonald, A. C., Carter, R., Tebbutt, N. C., Goldstein, D., Shannon, J., Dervenis, C., Glimelius, B., Deakin, M., Charnley, R. M., Anthoney, Alan, Lerch, M. M., Mayerle, J., Oláh, A., Büchler, M. W., Greenhalf, W.
Publicado en Br J Cancer (2018)